CIM
WST icon

CIM Investment Management’s West Pharmaceutical WST Stock Holding History

CIM Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472K Sell
1,884
-8
-0.4% -$1.99K 0.13% 140
2025
Q4 		$521K Hold
1,892
– – 0.14% 123
2025
Q3 		$496K Sell
1,892
-18
-0.9% -$4.38K 0.13% 127
2025
Q2 		$418K Sell
1,910
-8
-0.4% -$1.71K 0.08% 191
2025
Q1 		$429K Sell
1,918
-2
-0.1% -$551 0.1% 131
2024
Q4 		$629K Sell
1,920
-12
-0.6% -$3.78K 0.18% 98
2024
Q3 		$580K Sell
1,932
-60
-3% -$18.4K 0.17% 108
2024
Q2 		$656K Sell
1,992
-20
-1% -$7.07K 0.2% 98
2024
Q1 		$796K Hold
2,012
– – 0.24% 85
2023
Q4 		$708K Hold
2,012
– – 0.23% 91
2023
Q3 		$755K Sell
2,012
-45
-2% -$17.4K 0.28% 76
2023
Q2 		$787K Buy
2,057
+5
+0.2% +$1.79K 0.27% 79
2023
Q1 		$711K Buy
2,052
+91
+5% +$26.6K 0.26% 84
2022
Q4 		$462K Buy
1,961
+924
+89% +$219K 0.18% 123
2022
Q3 		$255K Buy
+1,037
New +$316K 0.11% 173
2016
Q2 		– Sell
-7,275
Closed -$504K – 312
2016
Q1 		$504K Buy
7,275
+957
+15% +$57.6K 0.22% 128
2015
Q4 		$380K Hold
6,318
– – 0.17% 147
2015
Q3 		$342K Buy
6,318
+757
+14% +$44.1K 0.17% 155
2015
Q2 		$323K Hold
5,561
– – 0.14% 155
2015
Q1 		$335K Hold
5,561
– – 0.15% 156
2014
Q4 		$296K Buy
5,561
+769
+16% +$38.5K 0.14% 163
2014
Q3 		$214K Buy
+4,792
New +$204K 0.11% 173

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIM Investment Management's WST Position: Q1 2026 in Review

CIM Investment Management reduced its West Pharmaceutical (WST) stake by 0.42% in Q1 2026, selling an estimated $1.99K and leaving 1,884 shares worth $472K. The position accounts for 0.13% of the portfolio, ranked #140.

CIM Investment Management first reported a position in WST in Q3 2014 and has held it in 22 quarters since. The position peaked at $796K in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • CIM Investment Management held 1,884 shares of West Pharmaceutical worth $472K as of Q1 2026.
  • CIM Investment Management sold 8 West Pharmaceutical shares in Q1 2026, an estimated $1.99K.
  • West Pharmaceutical made up 0.13% of CIM Investment Management's portfolio in Q1 2026, its #140 holding.
  • CIM Investment Management first reported a position in West Pharmaceutical in Q3 2014 and has held it in 22 quarters since.
  • CIM Investment Management's West Pharmaceutical position peaked at $796K in Q1 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.